Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Devon Grote

1PUBLICATIONS
32CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

Sort by Publication Date:
|Jun 26, 2020
Tumor-targeted CD28 bispecific antibodies enhance the antitumor efficacy of PD-1 immunotherapy.

Janelle C Waite, Bei Wang, Lauric Haber

Pageof 1

Frequent Collaborators

1 joint publications

Janelle C Waite

1 joint publications

Bei Wang

1 joint publications

Lauric Haber

1 joint publications

Aynur Hermann

1 joint publications

Erica Ullman

1 joint publications

Xuan Ye

1 joint publications

Drew Dudgeon

1 joint publications

Qi Wu

1 joint publications

Patrick Poon

1 joint publications

Jacquelynn Golubov

Frequent Collaborators

1 joint publications

Janelle C Waite

1 joint publications

Bei Wang

1 joint publications

Lauric Haber

1 joint publications

Aynur Hermann

Top Related Videos

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology
07:04

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Published on : May 02, 2025

932
See more related videos

Top Related Videos

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology
07:04

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Published on : May 02, 2025

932
See more related videos